Expert Speaker Faculty

Meet the Fibrosis Innovators Shaping the Future of Antifibrotic Therapies

Take a look at the esteemed speaker faculty for the 9th Antifibrotic Drug Development Summit 2025, featuring 25+ luminaries from top pharmaceutical companies, biotech innovators, and leading academic institutions. These experts will share groundbreaking research, clinical insights, and strategic visions to accelerate fibrosis drug development:

Ahmed Mousa - Vicore Pharma

Ahmed Mousa

Chief Executive Officer

Vicore Pharma

Anna Zagorska - Gilead Sciences

Anna Zagorska

Director, Inflammation & Fibrosis

Gilead Sciences

Caroline Phillips - Redx Pharma

Caroline Phillips

Chief Scientific Officer

RedX Pharma

Daniel Wilcock - RedX Pharma

Daniel Wilcock

Principal Translational Scientist

RedX Pharma

Dori Thomas-Karyat - Synthis Therapeutics

Dori Thomas-Karyat

Chief Executive Officer

Synthis Therapeutics

Gary Sweeney - Toronto BioScience

Gary Sweeney

Scientific Advisory Board Member & Professor

Allysta Pharmaceuticals Inc. & York University

Henrik Langdren - Abbvie

Henrik Landgren

Scientific Director, Precision Medicine Immunology & Fibrosis

Abbvie

Jeffrey Bornstein - Mediar Therapeutics

Jeffrey Bornstein

Chief Medical Officer

Mediar Therapeutics

Jen-Chieh Chuang

Program, Translational Medicine & Biomarker Lead

Takeda Pharmaceutical

John Nicosia - Vasarya

John Nicosia

Co-Founder & Chief Operating Officer

Vasarya Therapeutics

Katie McCauley - Novartis

Katie McCauley

Director & Portfolio Strategy & Fibrosis Research Lead

Novartis

Kevin Hart

Associate Research Fellow, Scientific Director, Fibrosis Exploratory Biology and Drug Discovery Group

Pfizer

Lee Borthwick, COO, Fibrofind, 8th Antifibrotic Drug Development Summit 2024

Lee Borthwick

Chief Operating Officer

FibroFind

Leslie Nangle - aTyr Pharma

Leslie Nangle

Vice President, Research

aTyr Pharma Inc.

Louise Goksøyr - AdaptVac

Louise Goksøyr

Project Lead & Scientist

AdaptVac

Mehrsa Mehrabi - Viscient Bio

Mehrsa Mehrabi

Senior Scientist

Viscient Biosciences

Min Lu - Eli Lilly

Min Lu

Executive Director

Eli Lilly & Co.

Rebecca Taub - Madrigal Pharmaceuticals

Rebecca Taub

Chief Executive Officer

Madrigal Pharmaceuticals

Remi Laberge - Arda Therapeutics

Remi Laberge

CTO

Arda Therapeutics

Rob Menzies - AstraZeneca

Rob Menzies

Senior Director

AstraZeneca

Rui Wu - Graviton Science

Rui Wu

Chief Officer ,Senior Vice President & Head of Research & Preclinical ,Chemistry, Manufacturing & Controls

Graviton BioScience

Sydney Montesi

Pulmonary & Critical Care Medicine Physician

Massachusetts General Hospital

Vipin Kumar

Co-Founder & Chief Scientific Officer

GRI Bio

Yury Popov

Co-Director, Pathogens Immunity & Inflammation Translational Hub & Associate Professor, Medicine

Beth Israel Deaconess Medical Center

Full Event Guide
Register
Partner